Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.85 +0.13 (+1.49%)
At close: Oct 21, 2026 · 4:00 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Cash from Operations (2021 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) posted Cash from Operations of -$2.12 million for Q2 2026, compared with -$1.14 million a year earlier.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Cash from Operations (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Operations at Aspire Biopharma Holdings was -$7.19 million; for FY2025, it came in at -$4.92 million.

  • In prior years, Aspire Biopharma Holdings' Cash from Operations was -$265,186 in FY2024, -$653,107 in FY2023, -$1.41 million in FY2022 and -$238,596 in FY2021.
  • Quarterly Cash from Operations has run from a low of -$3.04 million in Q1 2026 to a high of $479,569 in Q4 2024 over five years.
  • According to Business Quant data, Cash from Operations for the three prior quarters was -$3.04 million (Q1 2026), -$927,841 (Q4 2025) and -$1.1 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.12 Mn
Mar 31, 2026 -3.04 Mn
Dec 31, 2025 -927,841.00
Sep 30, 2025 -1.10 Mn
Jun 30, 2025 -1.14 Mn
Mar 31, 2025 -1.75 Mn
Dec 31, 2024 479,569.00
Sep 30, 2024 -495,540.00
Jun 30, 2024 -56,244.00
Mar 31, 2024 -192,971.00
Dec 31, 2023 -156,128.00
Sep 30, 2023 -124,921.00
Jun 30, 2023 -189,951.00
Mar 31, 2023 -182,107.00
Dec 31, 2022 -35,870.00
Sep 30, 2022 -46,622.00
Jun 30, 2022 -38,371.00
Mar 31, 2022 -1.29 Mn
Dec 31, 2021 -25,870.00
Sep 30, 2021 -181,811.00
API Access

Aspire Biopharma Holdings, Inc. Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ASBP&period=max&api_key=YOUR_API_KEY